0. DOCID:31319 SCORE: 0.00311012224593751
DOCNO: 12087457
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Air Pollution, Indoor
DESCRIPTOR: Environmental Exposure
DESCRIPTOR: Gamma Rays
DESCRIPTOR: Housing
PUBTYPE: Journal Article
PUBTYPE: Multicenter Study
JOURNALTITLE: British journal of cancer.
COUNTRY: Scotland
TITLE: The United Kingdom Childhood Cancer Study of exposure to domestic sources of ionising radiation: 2: gamma radiation.
PUBDATE: 20020601
This article reports measurements of household levels of gamma and cosmic rays at the addresses of children with cancer at the time of diagnosis and six months before, and of similar data at the addresses of control children. There is no indication of increased risk with increasing dose rates either in matched or unmatched analyses, with or without adjustment for deprivation. Sub-division by diagnostic group did not reveal any association with any specific types of malignancy. Studies of the relationship between household gamma rays and radon concentration show no evidence of any interactions.


1. DOCID:19944 SCORE: 0.00234396088223097
DOCNO: 8339238
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Mammography
QUALIFIER: diagnosis
QUALIFIER: mortality
AUTHOR: D B Kopans DB
AFFILIATION: Department of Radiology, Massachusetts General Hospital, Boston 02114.
PUBTYPE: Journal Article
JOURNALTITLE: Cancer.
COUNTRY: UNITED STATES
TITLE: Breast cancer detection in an institution. Is mammography detrimental?
PUBDATE: 19930801
The poor results of the National Breast Screening Study of Canada regarding the screening of women aged 40-49 have been interpreted to suggest that mammography might be detrimental. Our comparison of women who had mammography and had their cancers detected by mammography with women who did not have mammography and had palpable cancers suggest that this is not the case. There is no detrimental effect; rather, the use of mammography results in an improvement in survival. The poor results of the National Breast Screening Study likely are due to the unbalanced allocation of women with advanced cancers to the screened group, the poor quality of the mammography in the trial, and an insufficient sample size.


2. DOCID:19540 SCORE: 0.00204341543819157
DOCNO: 8081039
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: pathology
AUTHOR: B Chevallier B
AFFILIATION: Service d'oncologie médicale, centre régional de lutte contre le cancer Henri-Becquerel, Rouen, France.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Bulletin du cancer.
COUNTRY: FRANCE
TITLE: [Inflammatory breast cancer]
PUBDATE: 19931201
Inflammatory breast cancer is a rare disease characterized by a frequently fatal outcome despite combined modality approach used. Its precise definition is mainly clinical. A positive skin biopsy does not seem to be mandatory to establish the diagnosis. Induction chemotherapy applied before loco regional treatment has improved the 5 year overall survival. This chemotherapy is followed by a loco regional treatment consisting of either surgery or radiotherapy. The use of adjuvant chemotherapy is classical but its real value has never been assessed by appropriate randomized trials. Therapeutic improvements will perhaps come from more intensive induction chemotherapy regimen or from intensification of adjuvant treatment. Adequate randomized trials are needed to progress with this disease.


3. DOCID:25916 SCORE: 0.00203200495167608
DOCNO: 10568682
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: adverse effects
QUALIFIER: adverse effects
QUALIFIER: drug therapy
QUALIFIER: chemically induced
AUTHOR: A Gurjal A
AUTHOR: T An T
AUTHOR: M Valdivieso M
AUTHOR: G P Kalemkerian GP
AFFILIATION: The Department of Internal Medicine, Wayne State University and the Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: Lung cancer (Amsterdam, Netherlands)
COUNTRY: IRELAND
TITLE: Etoposide-induced pulmonary toxicity.
PUBDATE: 19991101
After treatment with etoposide, two patients with lung cancer developed interstitial infiltrates and respiratory failure. Of the two, one patient responded rapidly to steroid therapy and developed recurrent symptoms on re-challenge with etoposide. Both patients had histopathologic findings consistent with drug-induced pulmonary toxicity. Etoposide-induced lung disease needs to be considered in patients who develop subacute dyspnea and interstitial infiltrates during treatment with this agent.


4. DOCID:25944 SCORE: 0.0020320037097106
DOCNO: 9810418
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapeutic use
QUALIFIER: drug therapy
AUTHOR: M Pawlicki M
AUTHOR: J Rolski J
AUTHOR: B Wiczyńska B
AUTHOR: U Rychlik U
AFFILIATION: Kliniki Chemioterapii Centrum Onkologii, Oddział w Krakowie.
PUBTYPE: Clinical Trial
PUBTYPE: Journal Article
JOURNALTITLE: Ginekologia polska.
COUNTRY: POLAND
TITLE: [Evaluation of efficacy and toxicity of PC chemotherapy (cisplatin, cyclophosphamide) administered with amifostine in patients with clinically advanced ovarian cancer]
PUBDATE: 19980701
Twenty patients with advanced ovarian cancer were treated with chemotherapy PC (cisplatin 100 mg/m2, cyclophosphamide 1000 mg/m2) administered with amifostine. Sixty five percent of patients had objective response with 25% complete response rate. Tolerance of treatment was satisfactory. Only in 1 patients side effects were the reason of treatment interruption. Amifostine markedly decreases chemotherapy toxicity, mainly hematological and does not seem to influence the efficacy of chemotherapy.


5. DOCID:19157 SCORE: 0.0017307973976679
DOCNO: 2280152
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: pathology
QUALIFIER: pathology
AUTHOR: S Bahadur S
AFFILIATION: Department of E.N.T., All India Institute of Medical Sciences, New Delhi.
PUBTYPE: Journal Article
JOURNALTITLE: The Journal of laryngology and otology.
COUNTRY: ENGLAND
TITLE: Mandibular involvement in oral cancer.
PUBDATE: 19901201
It is difficult to predict the tumour invasion into the mandible by oral cancer pre-operatively, and consequently the decision to preserve or sacrifice the mandible is largely individualistic. The present study of 44 cases analyses the reliability of pre-operative parameters to assess mandibular involvement. Clinical, radiological and scintigraphic features have been compared with the detailed histology of the bone. This study confirms the usefulness of superior marginal resections in lesions which are close to but not involving the mandible, as well as for superficial lesions which are actually seen to involve the mandible but their CT and bone scans are negative for tumour invasion.


6. DOCID:26356 SCORE: 0.00169778629591597
DOCNO: 11090989
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Plants, Medicinal
QUALIFIER: therapy
AUTHOR: J G Graham JG
AUTHOR: M L Quinn ML
AUTHOR: D S Fabricant DS
AUTHOR: N R Farnsworth NR
AFFILIATION: Program for Collaborative Research in the Pharmaceutical Sciences, College of Pharmacy, 833 South Wood Street, Chicago IL 60612, USA.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Journal of ethnopharmacology.
COUNTRY: IRELAND
TITLE: Plants used against cancer - an extension of the work of Jonathan Hartwell.
PUBDATE: 20001201
A survey of plants used ethnomedically against cancer was undertaken, using the NAPRALERT database currently maintained by the Program for Collaborative Research in the Pharmaceutical Sciences, College of Pharmacy, University of Illinois-Chicago. We report over 350 species which are reported to be used against cancer and not cited in the work of Jonathan Hartwell, "Plants used against cancer: a survey", including previously unrepresented genera and families.


7. DOCID:30385 SCORE: 0.00168274290784681
DOCNO: 15024383
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: analogs & derivatives
QUALIFIER: metabolism
QUALIFIER: metabolism
AUTHOR: Hirofumi Tachibana H
AUTHOR: Kiyoshi Koga K
AUTHOR: Yoshinori Fujimura Y
AUTHOR: Koji Yamada K
AFFILIATION: Department of Bioscience and Biotechnology, Faculty of Agriculture, Kyushu University, Hakozaki 6-10-1, Fukuoka, 812-8581, Japan. tatibana@agr.kyushu-u.ac.jp
PUBTYPE: Journal Article
JOURNALTITLE: Nature structural & molecular biology.
COUNTRY: United States
TITLE: A receptor for green tea polyphenol EGCG.
PUBDATE: 20040401
The major polyphenol in green tea, (-)-epigallocatechin-3-gallate (EGCG), has been shown to prevent carcinogenesis. We have identified a receptor that mediates the anticancer activity of EGCG. Expression of the metastasis-associated 67-kDa laminin receptor confers EGCG responsiveness to cancer cells at physiologically relevant concentrations. Experiments using surface plasmon resonance demonstrate binding of EGCG to the 67-kDa laminin receptor with a nanomolar K (d) value.


8. DOCID:23336 SCORE: 0.0014867469820527
DOCNO: 8697118
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: methods
QUALIFIER: nursing
QUALIFIER: methods
AUTHOR: B K Shelton BK
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: AACN clinical issues.
COUNTRY: UNITED STATES
TITLE: Issues and trends in critical care of patients with cancer.
PUBDATE: 19960201
The specialty of critical care oncology has emerged as a result of changes in treatment of malignancies and technologic critical care developments. In this article, the author provides the experienced critical care nurse with an overview of the practice of critical care oncology and the unique needs of these patients. Methods for predicting critical illnesses in specialized cancer populations are provided. Also included is a summary of universal cancer care issues such as bone marrow suppression, venous access, chronic pain, and nutrition disorders that cross all specialty areas. This article serves as a basis and resource for practicing critical care nurses and includes background information for the other articles included in this journal issue.


9. DOCID:23936 SCORE: 0.0014256071589745
DOCNO: 8965352
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: diagnosis
QUALIFIER: analysis
AUTHOR: H Ohkura H
AFFILIATION: Medical Oncology Division, National Cancer Center Hospital.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Nippon rinsho. Japanese journal of clinical medicine.
COUNTRY: JAPAN
TITLE: [Tumor associated biomarker for early diagnosis of cancer]
PUBDATE: 19960501
It is almost impossible to diagnose early cancers by elevated tumor markers in serum. However, it is possible by detecting tumor associated biomarkers in the excreted specimens such as nipple discharge, urine and feces. Elevated CEA in nipple discharge is indicative of non-palpable "To" early breast cancer, elevated fecal CEA indicated hemoccult test-negative colon cancer, basic fetoprotein and beta-hCG core fragment in the urine for urogenital malignancies, and urinary VMA or HVA for asymptomatic neuroblastomas. Detection of abnormal genes is more sensitive than cytology and suggests cancers or precancerous changes. PCR-SSCP method enabled to determine Ki-ras gene mutation in pancreatic juice and in duodenal juice in pancreatic cancer patients.


10. DOCID:27161 SCORE: 0.00140502718780324
DOCNO: 10922963
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: complications
QUALIFIER: etiology
AUTHOR: J P Labat JP
AUTHOR: H Simon H
AUTHOR: J P Metges JP
AUTHOR: B Lucas B
AUTHOR: J P Malhaire JP
AFFILIATION: Fédération de Cancérologie, CHU - Hôpital Morvan, 5, avenue Foch, 29200 Brest. Jean-Paul.Labat@univ-brest.fr
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: Annales de médecine interne.
COUNTRY: FRANCE
TITLE: [Pyoderma gangrenosum and breast cancer: a new case]
PUBDATE: 20000601
We report here a new case of pyoderma gangrenosum (PG) associated with a breast cancer in a 39-year-old woman. We only found in literature three other reports of this rare entity which seems usually to be associated with monoclonal gammopathy, gastro-intestinal diseases such as Crohn's disease, chronic ulcerative colitis, leukemias or rheumatologic diseases. A commun hapten between of tumor and skin may explain the origin of this inflammatory lesion. In our case, PG could be a paraneoplastic syndrome.


11. DOCID:25455 SCORE: 0.00140488348871843
DOCNO: 11516603
AUTHOR: S Krishna S
AUTHOR: V T Chang VT
AUTHOR: J A Shoukas JA
AUTHOR: J Donahoo J
AFFILIATION: Department of Medicine, University of Medicine and Dentistry New Jersey/New Jersey Medical School, Newark, NJ 07018, USA.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: Journal of pain and symptom management.
COUNTRY: United States
TITLE: Video-assisted thoracoscopic sympathectomy-splanchnicectomy for pancreatic cancer pain.
PUBDATE: 20010701
Patients with unresectable pancreatic cancer often suffer severe pain. Various techniques are available for pain control. We present a patient with pancreatic cancer who underwent unilateral video-assisted thoracoscopic sympathectomy-splanchnicectomy and had complete pain relief. This minimally invasive procedure offers promise in carefully selected patients with severe pain from pancreatic cancer and other conditions which are not amenable to conventional interventions.


12. DOCID:24927 SCORE: 0.00140487098426381
DOCNO: 11411565
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: chemistry
QUALIFIER: pharmacology
AUTHOR: P Magiatis P
AUTHOR: H Pratsinis H
AUTHOR: E Kalpoutzakis E
AUTHOR: A Konstantinidou A
AUTHOR: P Davaris P
AUTHOR: A L Skaltsounis AL
AFFILIATION: Department of Pharmacy, University of Athens, Greece.
PUBTYPE: Journal Article
JOURNALTITLE: Biological & pharmaceutical bulletin.
COUNTRY: Japan
TITLE: Hydrolyzable tannins, the active constituents of three Greek Cytinus taxa against several tumor cell lines.
PUBDATE: 20010601
Hydrolyzable tannins were found to be the active cytotoxic constituents of three Greek Cytinus taxa: Cytinus ruber, Cytinus hypocistis subsp. hypocistis and Cytinus hypocistis subsp. orientalis. The cytotoxic activity was evaluated against a broad spectrum of cancer cell lines. The structure of the active compounds was investigated with NMR and electrospray-MS/MS techniques.


13. DOCID:24957 SCORE: 0.00140487098414672
DOCNO: 11768872
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: diagnosis
QUALIFIER: blood
QUALIFIER: blood
PUBTYPE: Newspaper Article
JOURNALTITLE: TreatmentUpdate.
COUNTRY: Canada
TITLE: Looking at soluble CD23 levels to predict lymphoma.
PUBDATE: 20011001
As we noted in our first article on lymphoma, there isn't any quick and simple test to diagnose or predict which PHAs will develop this cancer. Nor are there any symptoms that specifically occur from having lymphoma. To try to remedy the situation, researchers in Italy have been monitoring levels of the a protein called soluble CD23 (sCD23) in the blood and fluid surrounding the brain--cerebrospinal fluid (CSF). They have found higher-than-normal levels of sCD23 in the CSF of PHAs who have brain lymphoma.


14. DOCID:29269 SCORE: 0.00139316388380331
DOCNO: 11940467
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: administration & dosage
QUALIFIER: drug therapy
QUALIFIER: administration & dosage
AUTHOR: Mario Campone M
AUTHOR: Pierre Fumoleau P
AFFILIATION: Service d'oncologie, Centre René-Gauducheau, boulevard Jacques-Monod, 44805 Saint-Herblain Cedex.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Bulletin du cancer.
COUNTRY: France
TITLE: [Weekly administration of paclitaxel in the treatment of metastatic breast cancer: from rational to practice]
PUBDATE: 20020301
Clinical studies showed that paclitaxel is active as single agent and in combination chemotherapy for the management of metastatic breast cancer. A variety of doses and administration schedules have been evaluated in phase II and III trials. Weekly administration of paclitaxel which is generally well tolerated increases the therapeutic index (efficacy/safety) resulting from anti-angiogenic and pro-apoptotic effects.